Oklahoma's November general election is today. What to know about state, local races
News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neoleukin Therapeutics Inc
(NQ:
NLTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
3.460 (1)
Ask (Size)
3.590 (5)
Prev. Close
3.490
Today's Range
N/A - N/A
52wk Range
3.180 - 3.680
Shares Outstanding
42,425,071
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
December 14, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 05, 2023
Via
Benzinga
Performance
More News
Read More
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
October 05, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 05, 2023
Via
InvestorPlace
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
September 22, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via
Benzinga
NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX
July 25, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)
July 24, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)
July 18, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Neoleukin Therapeutics To Merge With Neurogene: Creates Biotech Firm Focused On Genetic Medicines For Neurological Diseases
July 18, 2023
Via
Benzinga
NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders
July 18, 2023
From
Halper Sadeh LLC
Via
Business Wire
Neurogene and Neoleukin Announce Definitive Merger Agreement
July 18, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
US Stocks Turn Lower; S&P 500 Down 1%
March 09, 2023
Via
Benzinga
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 09, 2023
Via
Benzinga
US Stocks Pare Gains; BJ's Wholesale Club Earnings Top Views
March 09, 2023
Via
Benzinga
Neoleukin Therapeutics Seeks Strategic Alternatives, To Layoff More In Round 2 Within 6 Months
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 09, 2023
Via
Benzinga
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
March 09, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 09, 2023
Via
InvestorPlace
Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
March 08, 2023
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
Neoleukin Therapeutics, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via
Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
November 16, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.